Abstract
Hürthle cell, a rare form of thyroid carcinoma, has been reported only five times in patients with Grave's Disease. We present a case report and comprehensive review of the literature. Surgery should be considered in patients with both Graves' Disease and an expanding goiter. Initial high-dose radioiodine should be administered post-operatively in patients with Hürthle cell carcinoma. Serum thyroglobulin and 18-FDG total body PET imaging may be valuable in discovering residual or recurrent disease.
| Original language | English |
|---|---|
| Pages (from-to) | 366-368 |
| Number of pages | 3 |
| Journal | Missouri Medicine |
| Volume | 106 |
| Issue number | 5 |
| State | Published - Jan 1 2009 |